A Multiple Dose Study Of PD-0360324 In Patients With Active Cutaneous Lupus Erythematosus

NCT01470313 · clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
28
Enrollment
INDUSTRY
Sponsor class

Stopped See termination reason in detailed description.

Conditions

Interventions

Sponsor

Pfizer